Found 198 matching trials
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma
PHASE2The study is being conducted to evaluate the efficacy and safety of convers...
Location
Shandong Cancer Hospital and Institute
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma
PHASE2This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Location
Zhongshan Hospital, Fudan University
Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer
PHASE2This prospective real-world study aims to evaluate the effectiveness and sa...
Location
Air Force Military Medical University
Neo-TACE-HAIC for BCLC B Stage HCC
NAHepatocellular carcinoma (HCC) patients is a common disease in the East Asi...
Location
Sun Yat-sen University Cancer Center
Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT
N/AThis multicenter retrospective study evaluated consecutive patients with la...
Location
The Second Affiliated Hospital of Guangzhou Medical University
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
N/AHepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Location
Chinese PLA General hospital
FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis
PHASE2Try FOLFOX-HAIC combining bevacizumab or cetuximab for initially unresectab...
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria
PHASE3The purpose of this study is to evaluate the efficacy and safety of resecti...
Location
Dongguan People's Hospital
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
N/AThis study is conducted to evaluate the efficacy, prognosis, adverse effect...
Location
The Second Affiliated Hospital of Fujian Medical University
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
PHASE2This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Location
The Second Affiliated Hospital of Guangzhou Medical University